Navigation Links
PharmAthene Reports First Quarter 2012 Financial Results
Date:5/8/2012

s payable$

1,410,516$

1,445,700Accrued expenses and other liabilities2,850,0723,169,642Current portion of long term debt195,412-Short term debt857,808-Total current liabilities5,313,8084,615,342Other long term liabilities555,983449,709Long term debt, less current portion2,234,712-Derivative instruments2,878,3141,886,652Total liabilities10,982,8176,951,703Stockholders' equity:Common stock, $0.0001 par value; 100,000,000 shares authorized;
48,314,510 and 48,236,172 shares issued and outstanding at March 31, 2012
and December 31, 2011, respectively4,8324,824Additional paid-in-capital209,111,489208,525,917Accumulated other comprehensive income1,023,8911,010,522Accumulated deficit(196,369,345)(193,689,457)Total stockholders'
equity13,770,86715,851,806Total liabilities and stockholders' equity$

24,753,684$

22,803,509 PHARMATHENE, INC. 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSThree months ended March 31,20122011Revenue

$

6,149,052$

6,337,722Operating expenses:Research and development4,705,3575,820,374General and administrative2,948,4814,939,654Depreciation and amortization85,910117,629Total operating expenses7,739,74810,877,657Loss from operations(1,590,696)(4,539,935)Other income (expense):Interest income2,9883,154Interest expense(3,028)(15,435)Other income (expense)52,915(11,906)Change in fair value of derivative instruments(991,662)2,488,465Total other income (expense)(938,787)2,464,278Net loss before income taxes(2,529,483)(2,075,657) Income tax expense(150,405)- Net loss

$

(2,679,888)$

(2,075,657)Basic and diluted net loss per share

$

(0.06)$

(0.04)Weighted average shares used in calculation of
basic and diluted net loss per share48,269,89446,276,874 


'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
2. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
3. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
4. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
5. PharmAthene Reports Third Quarter 2011 Financial and Operating Results
6. PharmAthene Progresses Second Generation rPA Anthrax Vaccine
7. PharmAthene Appoints Brian A. Markison to the Companys Board of Directors
8. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
9. Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program
10. PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index
11. PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)...  Tikcro Technologies Ltd. (OTCQB: TIKRF) announced today that ... for the fiscal year ended December 31, 2014 with ... report on Form 20-F contains information regarding its biotechnology ... of cancer immune checkpoints. This project aims to develop ... binding in targeting certain identified immune checkpoints. The filing ...
(Date:5/4/2015)... - The Fight Against Cancer Innovation Trust (FACIT) ... formation of Turnstone Biologics Inc. (Turnstone), a biotechnology ... harness the patient,s own immune system. ... Children,s Hospital of Eastern Ontario ... Institute for Cancer Research (OICR), the Ottawa Hospital ...
(Date:5/4/2015)... Achieved primarily through a proprietary paraffin and stain additive, ... better detail than the industry standard. But because ... methods, it needed another medium to measure its detail. ... reference because it represents the highest standard of detail ... discovery days of Ultralight Histology was to reverse engineer ...
(Date:5/4/2015)... - New Massive Open Online Course (MOOC) ... United States Medical Licensing Examination Elsevier ... information products and services, announced today that it has ... to help medical students prepare for the United States ... most daunting of the three exams medical students must ...
Breaking Biology Technology:Tikcro Technologies Files Annual Report on Form 20-F for the Year Ended December 31, 2014 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3Elsevier's Free MOOC Prepares Med Students for Licensing Exam 2Elsevier's Free MOOC Prepares Med Students for Licensing Exam 3
... CHICAGO, March 20 Empirical Search Strategies, ... the Avigen, Inc.,s (Nasdaq: AVGN ) outstanding ... protection" measure described by the Biotechnology Value Fund ("BVF"). ... beneficial to all shareholders for the following reasons:, ...
... 20, Shire plc (LSE: SHP, NASDAQ: SHPGY ... U.S. District Court of the Southern District of,New York ... (collectively "Mylan") for infringement of Shire,s,patent: U.S. Patent No. ... lawsuit was filed in response to an Abbreviated New ...
... groups including the mentally ill, the disabled and ... fare worse than others in the aftermath of natural ... , Now, a new study by UCLA researchers ... terrorism-related fears and make more behavioral changes based on ...
Cached Biology Technology:Empirical Search Strategies Seeks Downside Protection Option at Avigen, Inc. 2Empirical Search Strategies Seeks Downside Protection Option at Avigen, Inc. 3Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent 2Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent 3Disabled and other vulnerable groups more susceptible to terrorism fears 2
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... of the "Global Iris Recognition Market 2015-2019" ... the Global Iris Recognition market to grow at a ... This report covers the present scenario and the ... the period 2015-2019. To calculate the market size, the ...
(Date:3/24/2015)... PALM BEACH GARDENS, Fla. , March 24, ... of biometric identity management solutions, today announced that ... enabling premium clothing accessory retailer Goorin Bros ... login. The Crossmatch biometrics-based solution secures access to ... customers from the increased risk of data breaches. ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... Scientists have long known that people who have a ... of starting to abuse alcohol. The reason for this has ... of Gothenburg, Sweden, provides part of the answer. The study ... an alcoholic react more positively to alcohol than other people. ...
... In a study to be published online this week in ... researchers report the discovery of a novel hepatitis C-like virus ... gives scientists new insights into how hepatitis C in humans ... a model system to study how it causes disease. ...
... spent more than four decades conducting botanical and ecological ... of land throughout the Northeast in areas such as West ... his ecological knowledge of the area in publications of regional ... Adirondack Research Consortium (ARC) today at the 18th Annual Conference ...
Cached Biology News:Heredity behind subjective effects of alcohol 2Discovery of canine hepatitis C virus opens up new doors for research on deadly human pathogen 2Discovery of canine hepatitis C virus opens up new doors for research on deadly human pathogen 3Scientist recognized for contributions to the sustainability of the Adirondacks 2
Screening assay to detect the Listeria monocytogenes in food samples by,DNA amplification and molecular hybridization on a microtiter plate....
... Application: Acridine orange has been used ... in agarose and polyacrylamide gels. Acridine orange ... detect purified DNA in gels with a ... has also been used extensively for cell ...
Miscellaneous: Versatile stain for staining RNA (bluish-purple), DNA (blue), proteins (red) and acid polysaccharides Assay: ~ 95 % Suitab tst: differential staining of nucleic acids and prote...
...
Biology Products: